Annual Retained Earnings
-$265.26 M
-$8.83 M-3.44%
31 December 2023
Summary:
Pharming Group NV annual retained earnings is currently -$265.26 million, with the most recent change of -$8.83 million (-3.44%) on 31 December 2023. During the last 3 years, it has risen by +$30.36 million (+10.27%). PHAR annual retained earnings is now -38.62% below its all-time high of -$191.36 million, reached on 31 December 2005.PHAR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$278.37 M
+$1.68 M+0.60%
30 September 2024
Summary:
Pharming Group NV quarterly retained earnings is currently -$278.37 million, with the most recent change of +$1.68 million (+0.60%) on 30 September 2024. Over the past year, it has dropped by -$15.60 million (-5.93%). PHAR quarterly retained earnings is now -14.78% below its all-time high of -$242.53 million, reached on 30 September 2022.PHAR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | -5.9% |
| 3 y3 years | +10.3% | -0.5% |
| 5 y5 years | +30.5% | +17.4% |
PHAR Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -3.4% | +10.3% | -14.8% | +0.6% |
| 5 y | 5 years | -3.4% | +30.5% | -14.8% | +18.3% |
| alltime | all time | -38.6% | +37.3% | -14.8% | +36.0% |
Pharming Group NV Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$278.37 M(-0.6%) |
| June 2024 | - | -$280.05 M(+1.0%) |
| Mar 2024 | - | -$277.39 M(+4.6%) |
| Dec 2023 | -$265.26 M(+3.4%) | -$265.26 M(+0.9%) |
| Sept 2023 | - | -$262.78 M(-1.0%) |
| June 2023 | - | -$265.49 M(-0.4%) |
| Mar 2023 | - | -$266.49 M(+3.9%) |
| Dec 2022 | -$256.43 M(-6.1%) | -$256.43 M(+5.7%) |
| Sept 2022 | - | -$242.53 M(-4.3%) |
| June 2022 | - | -$253.55 M(-6.3%) |
| Mar 2022 | - | -$270.50 M(-1.0%) |
| Dec 2021 | -$273.17 M(-7.6%) | -$273.17 M(-1.4%) |
| Sept 2021 | - | -$277.03 M(+0.0%) |
| June 2021 | - | -$276.99 M(-1.4%) |
| Mar 2021 | - | -$280.82 M(-5.0%) |
| Dec 2020 | -$295.62 M(-13.2%) | -$295.62 M(-6.9%) |
| Sept 2020 | - | -$317.70 M(+1.4%) |
| June 2020 | - | -$313.39 M(-1.6%) |
| Mar 2020 | - | -$318.46 M(-6.5%) |
| Dec 2019 | -$340.71 M(-10.7%) | -$340.71 M(+1.1%) |
| Sept 2019 | - | -$337.13 M(-7.3%) |
| June 2019 | - | -$363.65 M(-0.9%) |
| Mar 2019 | - | -$366.83 M(-3.9%) |
| Dec 2018 | -$381.65 M(-9.8%) | -$381.65 M(-5.7%) |
| Sept 2018 | - | -$404.58 M(-0.6%) |
| June 2018 | - | -$407.10 M(-6.5%) |
| Mar 2018 | - | -$435.32 M(+2.9%) |
| Dec 2017 | -$422.97 M | -$422.97 M(+14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | -$370.36 M(+5.0%) |
| June 2017 | - | -$352.76 M(+16.1%) |
| Mar 2017 | - | -$303.71 M(+3.5%) |
| Dec 2016 | -$293.45 M(+1.8%) | -$293.45 M(-4.1%) |
| Sept 2016 | - | -$305.99 M(+2.0%) |
| June 2016 | - | -$299.84 M(-0.8%) |
| Mar 2016 | - | -$302.22 M(+4.8%) |
| Dec 2015 | -$288.35 M(-7.6%) | -$288.35 M(-1.6%) |
| Sept 2015 | - | -$292.99 M(+1.0%) |
| June 2015 | - | -$290.11 M(+4.1%) |
| Mar 2015 | - | -$278.57 M(-10.7%) |
| Dec 2014 | -$311.94 M(-10.8%) | -$311.94 M(-14.3%) |
| Sept 2014 | - | -$364.15 M(-7.4%) |
| June 2014 | - | -$393.26 M(+0.6%) |
| Mar 2014 | - | -$390.79 M(+11.8%) |
| Dec 2013 | -$349.69 M(+0.2%) | -$349.69 M(-1.9%) |
| Sept 2013 | - | -$356.44 M(+5.3%) |
| June 2013 | - | -$338.60 M(+2.3%) |
| Mar 2013 | - | -$331.01 M(-5.1%) |
| Dec 2012 | -$348.82 M(+4.1%) | -$348.82 M(+3.0%) |
| Sept 2012 | - | -$338.78 M(+1.1%) |
| Dec 2011 | -$334.93 M(+4.4%) | -$334.93 M(+4.4%) |
| Dec 2010 | -$320.80 M(-14.6%) | -$320.80 M(-14.6%) |
| Dec 2009 | -$375.48 M(+18.5%) | -$375.48 M |
| Dec 2008 | -$316.79 M(+7.9%) | - |
| Dec 2007 | -$293.58 M(+23.8%) | - |
| Dec 2006 | -$237.13 M(+23.9%) | - |
| Dec 2005 | -$191.36 M | - |
FAQ
- What is Pharming Group NV annual retained earnings?
- What is the all time high annual retained earnings for Pharming Group NV?
- What is Pharming Group NV annual retained earnings year-on-year change?
- What is Pharming Group NV quarterly retained earnings?
- What is the all time high quarterly retained earnings for Pharming Group NV?
- What is Pharming Group NV quarterly retained earnings year-on-year change?
What is Pharming Group NV annual retained earnings?
The current annual retained earnings of PHAR is -$265.26 M
What is the all time high annual retained earnings for Pharming Group NV?
Pharming Group NV all-time high annual retained earnings is -$191.36 M
What is Pharming Group NV annual retained earnings year-on-year change?
Over the past year, PHAR annual retained earnings has changed by -$8.83 M (-3.44%)
What is Pharming Group NV quarterly retained earnings?
The current quarterly retained earnings of PHAR is -$278.37 M
What is the all time high quarterly retained earnings for Pharming Group NV?
Pharming Group NV all-time high quarterly retained earnings is -$242.53 M
What is Pharming Group NV quarterly retained earnings year-on-year change?
Over the past year, PHAR quarterly retained earnings has changed by -$15.60 M (-5.93%)